#adzynma نتائج البحث
FDA Approves Adzynma (ADAMTS13, recombinant-krhn) Enzyme Replacement Therapy as First Treatment for Congenital Thrombotic Thrombocytopenic Purpura (cTTP), a rare, chronic blood clotting disorder Drugs.com drugs.com/newdrugs/fda-a… #Adzynma
@TakedaPharma's Adzynma is the first approved therapy for the ultra-rare clotting disorder congenital thrombotic thrombocytopenic purpura. #Takeda #Adzynma #DrugDevelopment #Pharmaceuticals #BioSpace hubs.ly/Q028wVqh0
ADZYNMA 初の先天性血栓性血小板減少性紫斑病治療薬として米国 FDAが承認 武田薬品 #ADZYNMA #先天性血栓性血小板減少性紫斑病 #米国 #FDA #承認 #武田薬品 #医薬通信社 iyakutsushinsha.com/2023/11/10/adz…
iyakutsushinsha.com
ADZYNMA 初の先天性血栓性血小板減少性紫斑病治療薬として米国 FDAが承認 武田薬品
武田薬品は10日、ADZYNMA（遺伝子組換え ADAMTS13-krhn）について、先天性血栓性血小板減少性紫斑病（cTTP）治療における初めてかつ唯一の遺伝子組換えADAMTS13酵素補充療法として米国FDAが承認したと発表した。 対象...
Wolfgang @miesbach's Top 10 Picks for TTP and Thrombosis from @ASH_hematology 2025 hemostasistoday.com/insight/wolfga… #Abelacimab #ADAMTS13 #ADZYNMA #ASH2025 #AZALEATIMI71 #DOACs #Health #Hematology #Hemostasis #HemostasisToday #Medicine #MilvexianReversal #OKL1111 #Stroke #Thrombosis
hemostasistoday.com
Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025 - Hemostasis Today
Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
FDA, konjenital trombotik trombositopenik purpuralı yetişkin ve pediatrik hastalarda profilaktik (önleyici) veya isteğe bağlı enzim replasman tedavisi için belirtilen ilk rekombinant (genetiği değiştirilmiş) protein ürünü olan #Adzynma ’yı onayladı. winally.com/fda-nadir-kali…
Takeda's enzyme replacement therapy approved by FDA for rare blood clotting disorder dlvr.it/SymR9g #Takeda #USFoodandDrugAdministration #Adzynma
Takeda gets ADZYNMA FDA approval for cTTP treatment: A new era in rare disease therapy business-news-today.com/takeda-gets-ad… #cTTP #Takeda #ADZYNMA #FDAApproval #cTTPtreatment #MedicalBreakthrough #RareDiseases #HealthcareInnovation #PharmaceuticalNews
business-news-today.com
Takeda gets ADZYNMA FDA approval for cTTP treatment: A new era in rare
Explore Takeda's groundbreaking ADZYNMA, the first FDA-approved recombinant ADAMTS13 protein for cTTP treatment. A revolutionary step in rare disease therapy!
#Adzynma is the first product to be approved for the treatment of the #rareblood disorder that has 90% mortality when left untreated. Learn more: ajmc.com/view/fda-appro…
Hello #benignheme community. I am curious of the recent #FDA investigation about #Adzynma influences you to make any changes and what were those changes in your recommendation about the product. fda.gov/vaccines-blood…
Takeda’s #ADZYNMA (ADAMTS13, recombinant-krhn) now is approved by U.S. FDA as the First and Only a#Recombinant ADAMTS13 Enzyme Replacement Therapy for the Treatment of #Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
Takeda Reports the EC’s Approval of Adzynma to Treat Congenital Thrombotic Thrombocytopenic Purpura (cTTP) #takeda #adzynma #congenitalthromboticthrombocytopenicpurpura #regulatory #ec #approval #phase3 pharmashots.com/18733/takeda-r…
Adzynma Side Effects May Be Linked to Child’s Death, FDA Warns #Adzynma #Takeda #ThromboticThrombocytopeniaPurpura aboutlawsuits.com/adzynma-side-e…
aboutlawsuits.com
Adzynma Side Effects May Be Linked to Child’s Death, FDA Warns
The FDA is investigating the side effects of Adzynma, warning that patients taking the TTP treatment may develop neutralizing antibodies that put them at risk of severe injuries or death.
息子の疾患。最優先かつ大事な情報。 米国FDAで承認されました。 医薬品開発受託機関の社員研修で「息子にとっての新薬とは」を含む講演日（大阪会場）に一報が入りました。 息子と対話してみます。 #Adzynma #ADAMTS13 #TAKEDA takeda.com/jp/newsroom/ne…
#Adzynma received #FDA approval for the treatment of #cTTP in adult and pediatric patients, making it the first recombinant protein indicated for prophylactic and on-demand treatment of cTTP. ow.ly/bmYL50QykPv
ADZYNMA 先天性血栓性血小板減少性紫斑病のADAMTS13欠乏症治療薬として欧州委員会が承認 武田薬品 #ADZYNMA #欧州委員会 #承認 #武田薬品 #医薬通信社 iyakutsushinsha.com/2024/08/09/adz…
iyakutsushinsha.com
ADZYNMA 先天性血栓性血小板減少性紫斑病のADAMTS13欠乏症治療薬として欧州委員会が承認 武田薬品
武田薬品は8日、ADZYNMA （遺伝子組換えADAMTS13）について、欧州委員会（EC）が先天性血栓性血小板減少性紫斑病（cTTP）の小児および成人ADAMTS13欠乏症治療薬として承認したと発表した。ADZYNMAは、cTTPの治療を...
❗ #FDAApprovalAlert ❗ dtw Research would like to congratulate @TakedaPharma on the approval of #Adzynma! 🧬The brand is the #firstandonly #approved enzyme replacement therapy for the treatment of patients with #cTTP. Congratulations, #Takeda! 🎉
Prise en charge du traitement enzymatique substitutif #Adzynma* contre le purpura thrombotique thrombocytopénique congénital (PTTc) apmnews.com/story.php?obje…
Something went wrong.
Something went wrong.
United States Trends
- 1. Comey N/A
- 2. OPEC N/A
- 3. Fauci N/A
- 4. King Charles N/A
- 5. Rob Thomson N/A
- 6. Brad Stevens N/A
- 7. Kid Rock N/A
- 8. #lovelygrey N/A
- 9. Ariana N/A
- 10. Don Mattingly N/A
- 11. #LaSayonaExtorsionadora N/A
- 12. Petal N/A
- 13. David Morens N/A
- 14. Steel Wool N/A
- 15. #NoIllegalFloridaMaps N/A
- 16. Minneapolis N/A
- 17. Marie Harf N/A
- 18. Dombrowski N/A
- 19. #Pay_Attention_To_HYBE N/A
- 20. Topper N/A